Publicaciones (332) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Scientific reports, Vol. 14, Núm. 1, pp. 3000

  2. Calcium, Phosphorus, and Vitamin D Levels in a Series of Cystic Fibrosis Patients: A Cross-Sectional Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  3. Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

    Frontiers in Immunology, Vol. 15

  4. Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  5. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management

    United European Gastroenterology Journal, Vol. 12, Núm. 1, pp. 122-138

  6. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital

    Gastroenterologia y Hepatologia

  7. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Allergic asthma and viruses

    The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 167-179

  3. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Gut, Vol. 72, Núm. 11, pp. 2031-2037

  4. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Gut

  5. Copper/Zinc Ratio in Childhood and Adolescence: A Review

    Metabolites, Vol. 13, Núm. 1

  6. Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 439-445

  7. Duodenal pyogenic granuloma: An unusual cause of chronic anemia

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 9, pp. 530-531

  8. Early-onset colorectal cancer: an eleven-year analysis of clinicopathological characteristics at a tertiary healthcare center

    Arquivos de Gastroenterologia, Vol. 60, Núm. 3, pp. 315-321

  9. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  10. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

    Gut, Vol. 72, Núm. 6, pp. 1054-1072

  11. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  12. Esophageal epidermoid metaplasia. An unusual find

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 194-195

  13. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517